Eli Lilly, Merck add new combo alliance; Gilead really does want to focus on M&A
• Eli Lilly is taking its newly approved cancer drug Lartruvo and combining it with Keytruda in an expanded collaboration deal with Merck. This …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
